You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 10, October 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  CASE REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Immunological and Chromosomal Studies in a Patient With Sézary Syndrome

J. Corwin Vance, MD; Jaroslav Cervenka, MD, CSc; Susanne Ullman, MD; John H. Kersey, MD; Andrej Sabad; Nancy Green

Arch Dermatol. 1977;113(10):1417-1423.


Abstract

{dagger} A patient with the small-cell variant of Sézary syndrome was studied before and during treatment with low-dose chlorambucil. He had depressed responses to phytohemagglutinin (PHA) and concanavalin A that returned to normal with clinical improvement. Spontaneously dividing cells were found in the peripheral blood by culturing lymphocytes without PHA for 24 hours. Seventy-two-hour PHA-stimulated lymphocyte cultures revealed predominantly hypodiploid chromosome numbers. Both abnormalities improved during treatment. Lymphocytes that were studied for sister chromatid exchanges had an increased number of exchanges per metaphase. Immunofluorescence studies revealed immunoglobulins and C at the dermoepidermal junction and in the dermal vessel walls. Our findings demonstrate that the depression of mitogen responsiveness that is sometimes seen in Sézary syndrome can be favorably affected by chemotherapy. Likewise, some chromosomal abnormalities may regress during successful therapy. These findings may provide a way of measuring the response to therapy.

(Arch Dermatol 113:1417-1423, 1977)



Author Affiliations

From the Departments of Dermatology (Drs Vance and Ullman) and Laboratory Medicine and Pathology (Dr Kersey and Mr Sabad), and the Division of Oral Pathology and Genetics (Drs Cervenka, Ullman and Ms Green), University of Minnesota, Minneapolis; and the Section of Dermatology, Minneapolis Veterans Administration Hospital (Dr Vance).


Footnotes

Accepted for publication July 27, 1976.

Presented in part at the Society of Investigative Dermatology meeting, Atlantic City, June 1975.

Reprint requests to Department of Dermatology, Box 98 Mayo Bldg, University of Minnesota Hospital, Minneapolis, MN 55455 (Dr Vance).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.